Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery (FLAME)
Primary Purpose
Age Related Cataracts, Cystoid Macular Edema
Status
Unknown status
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Femtosecond Laser
Manual Cataract Surgery
Sponsored by
About this trial
This is an interventional diagnostic trial for Age Related Cataracts
Eligibility Criteria
Inclusion Criteria:
- Bilateral Age-related cataract necessitating lens extraction and posterior IOL implantation
- Age 40 and older (females of childbearing age will be interviewed if pregnancy is possible)
Exclusion Criteria:
- Corneal abnormality
- Preceding ocular surgery or trauma
- Uncontrolled glaucoma
- Proliferative diabetic retinopathy
- Macular degeneration
- Iris neovascularization
- History of uveitis/iritis
- Microphthalmus
- Recurrent intraocular inflammation of unknown etiology
- Blind fellow eye
- Uncontrolled systemic or ocular disease
Sites / Locations
- Medical University of Vienna
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Femtosecond Laser assisted Cataract Surgery
Manual Cataract Surgery
Arm Description
Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order.
Manual Cataract Surgery will be performed in contralateral (to LCS) eye of patient with bilateral age-related cataract.
Outcomes
Primary Outcome Measures
Central Macular Thickness
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)
Secondary Outcome Measures
Influence of lens density on quantitative autofluorescence
Influence of lens density on quantitative autofluorescence will be assessed in qAF units. Images will be recorded after volume scans for each eye on designated visits.
Quantitative Autofluorescence quantifies natural fundus autofluorescence with a Spectralis HRA+OCT. This method uses the same wavelength and confocal scanning laser ophthalmoscope as fundus autofluorescence (488nm; maximum power: 280 µW) and can be used to determine the integrity and vitality of the retinal pigment epithelium which is important for nourishment the retina.
Central Macular Thickness
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)
Full Information
NCT ID
NCT03465124
First Posted
March 1, 2018
Last Updated
March 6, 2019
Sponsor
Medical University of Vienna
1. Study Identification
Unique Protocol Identification Number
NCT03465124
Brief Title
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
Acronym
FLAME
Official Title
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery - FLAME
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 26, 2018 (Actual)
Primary Completion Date
February 19, 2019 (Actual)
Study Completion Date
April 6, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigational device is an approved femtosecond laser (FSL) device with an integrated imaging system to perform certain steps of the cataract procedure. The FSL will perform anterior capsulotomy and lens fragmentation in individuals suffering from age-related cataract with need of cataract surgery.
Cataract surgery will be performed in subjects who have signed an informed consent form. Macula thickness will be measured with Spectralis OCT on screening date.
Postoperative examinations will be implemented in accordance with the approved investigational plan on subjects and includes: visual acuity, slitlamp examination, retinal oct imaging and quantitative autofluorescence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Age Related Cataracts, Cystoid Macular Edema
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Bilateral cataract surgery will be performed in individuals with age-related cataract. Eyes will be randomized into two groups receiving either Femtosecond Laser assisted Cataract Surgery (LCS) or conventional Manual Cataract Surgery (MCS).
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Groups will be randomized. Randomization information will be put in a sealed envelope on screening date and opened in operating theatre right before procedure start.
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Femtosecond Laser assisted Cataract Surgery
Arm Type
Active Comparator
Arm Description
Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order.
Arm Title
Manual Cataract Surgery
Arm Type
Active Comparator
Arm Description
Manual Cataract Surgery will be performed in contralateral (to LCS) eye of patient with bilateral age-related cataract.
Intervention Type
Device
Intervention Name(s)
Femtosecond Laser
Intervention Description
Femtosecond Laser assisted Cataract Surgery will be performed unilateral in randomized order. Contralateral eye will receive conventional cataract surgery
Intervention Type
Other
Intervention Name(s)
Manual Cataract Surgery
Intervention Description
conventional cataract surgery as control
Primary Outcome Measure Information:
Title
Central Macular Thickness
Description
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)
Time Frame
Baseline to 6 weeks postoperative
Secondary Outcome Measure Information:
Title
Influence of lens density on quantitative autofluorescence
Description
Influence of lens density on quantitative autofluorescence will be assessed in qAF units. Images will be recorded after volume scans for each eye on designated visits.
Quantitative Autofluorescence quantifies natural fundus autofluorescence with a Spectralis HRA+OCT. This method uses the same wavelength and confocal scanning laser ophthalmoscope as fundus autofluorescence (488nm; maximum power: 280 µW) and can be used to determine the integrity and vitality of the retinal pigment epithelium which is important for nourishment the retina.
Time Frame
Baseline to 1 weel, 3 weeks and 6 weeks postoperative
Title
Central Macular Thickness
Description
Difference in Central Macular Thickness (CMT) between Femtosecond Laser-assisted Cataract Surgery (LCS) to Manual Cataract Surgery (MCS)
Time Frame
Baseline to 1 week, 3 weeks, 6 weeks postoperative
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Bilateral Age-related cataract necessitating lens extraction and posterior IOL implantation
Age 40 and older (females of childbearing age will be interviewed if pregnancy is possible)
Exclusion Criteria:
Corneal abnormality
Preceding ocular surgery or trauma
Uncontrolled glaucoma
Proliferative diabetic retinopathy
Macular degeneration
Iris neovascularization
History of uveitis/iritis
Microphthalmus
Recurrent intraocular inflammation of unknown etiology
Blind fellow eye
Uncontrolled systemic or ocular disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rupert Menapace, MD
Organizational Affiliation
Medical Universitiy of Vienna
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical University of Vienna
City
Vienna
ZIP/Postal Code
1090
Country
Austria
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34135449
Citation
Reiter GS, Schwarzenbacher L, Schartmuller D, Roggla V, Leydolt C, Menapace R, Schmidt-Erfurth U, Sacu S. Influence of lens opacities and cataract severity on quantitative fundus autofluorescence as a secondary outcome of a randomized clinical trial. Sci Rep. 2021 Jun 16;11(1):12685. doi: 10.1038/s41598-021-92309-6.
Results Reference
derived
Learn more about this trial
Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery
We'll reach out to this number within 24 hrs